ProCE Banner Activity

Expert Tips for Identification and Clinical Management of Postpartum Depression

Clinical Thought

In this brief commentary, a psychiatrist specializing in women’s health shares key insights and clinical guidance based on her experience treating women with postpartum depression.

Released: December 22, 2023

Share

Faculty

Anita H. Clayton

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Nurse Practitioners in Women's Health (NPWH).

ProCE Banner

Supporters

Supported by an educational grant from Sage Therapeutics, Inc.

Sage Therapeutics, Inc.

Partners

NPWH

ProCE Banner

Faculty Disclosure

Primary Author

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Anita H. Clayton, MD, DLFAPA, IF: grants: Dare Bioscience, Janssen, Neumora Therapeutics, Otsuka, Praxis Precision Medicines, Relmada Therapeutics, Sage Therapeutics; consultant/advisor: AbbVie, Biogen, Brii Biosciences, Fabre-Kramer, Initiator Pharma, Janssen Research & Development, LLC, MindCure, Ovoca Bio, Praxis Precision Medicines, PureTech Health, Reunion Neuroscience, S1 Biopharma, Sage Therapeutics, Sertsei Pharmaceuticals, Takeda/Lundbeck, Vella Bioscience, WCG MedAvante-ProPhase; stock/stock options: Euthymics, S1 Biopharma.